Delivery Order SPE2DX22D0049-SPE2D826FA0SU
- Not listed
- This delivery order, awarded on October 14, 2025, represents a $1,639.62 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract utilizes a non-competitive delivery order structure as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- This delivery order, awarded July 21, 2025, represents a $24,150.64 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp for pharmaceutical and medical supply fulfillment. The contract, which serves as a child order under a larger indefinite delivery vehicle, is scheduled for completion by July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This delivery order, awarded October 20, 2025, represents a $7,206.03 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is not set-aside and was competitively awarded through the Medical Supply Chain, a defense-focused federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $81,617.60 on October 20, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price delivery order, which is a child action under a larger indefinite delivery contract (IDC), calls for pharmaceutical and medical supply deliveries to be completed by October 21, 2025. The award was made competitively without set-aside designation to AmerisourceBergen Drug Corp's Corporate Office, headquartered...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,930.98 on October 13, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is expected to be completed by October 14, 2025, represents a child contract under a larger indefinite delivery contract (IDC) vehicle. The award was competitively procured with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,726.13 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 30, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award demonstrates the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA0SUDelivery Order
This delivery order, awarded on October 20, 2025, represents a $13,413.71 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision. The contract, which is a child award under a larger indefinite delivery vehicle, was issued by the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by October 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's prime indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global contract vehicle to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The contract was competitively awarded without set-aside provisions, reflecting the company's demonstrated capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 10/20/25 |